SYK Stryker Corp.

$SYK after listening to the CFO comments the issues causing the sell off seem very acute and short term AND they still believe the guidance could be met. 2027 sounds very positive as well. Big overreaction in my opinion, market always over shoots. Share buy backs on the docket too

$SYK never seen so much damage caused by a CFO remarks at a conference. Hopefully they can unfuck this at earnings

$SYK I love this stock at these levels. It has solid fundamentals and presents a very compelling valuation currently (NFA).

$SYK Stifel cut its Stryker target to 330 from 360 this morning but kept the Buy. The detail worth reading: Stifel's 2026 organic growth estimate, 8.3%, is now the very bottom of Stryker's 8.3 to 9.3% guidance range. Its 14.96 EPS estimate sits basically at the low end of the 14.95 to 15.10 guide. The quarter was fine: Q2 EPS 3.69 vs 3.49 expected, revenue up 9.4% to 6.59 billion. The caution is entirely second-half, orthopedics demand and elective procedure timing. So the call is the guide's floor and the rating is still Buy. Stifel names delayed elective joints and backlog conversion as the upside case. The stock is around 278, down about 29% from the 52-week high.

$SYK they have to come out and reiterate the guidance or show some confidence with executive purchases or buy backs.

$SYK over the next 10 years, they’re gonna get a lot of business with a lot of people getting into that age bracket. I’m a buyer. 

Stryker Stock In Focus As Truist Says CEO Transition Is Low-Risk, Cuts Price Target To $310 $SYK https://stocktwits.com/news/equity/markets/stryker-stock-in-focus-as-truist-says-ceo-transition-is-low-risk-cuts-price-target-to-310/cZDtfVSRBlf

$SYK one of the best names in med device starting to get attractive 4 hour RSI is now sub 15 $SPY

$SYK Someone asked me to chart. No idea what the company does. Monthly candles. Uptrend close to breaking down. Even if it wasn't, it doesn't look enticing to me.